The aim is to encompass a cohort of 60 patients with early esophageal cancer (cT1N0M0), measuring peripheral plasma D-dimer levels alongside tumor markers like carcinoembryonic antigen to establish a more comprehensive understanding of D-dimer’s diagnostic value. This evidence concerns the gene CEACAM5 and neoplasm.